Corrigendum to “Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials”
Titel:
Corrigendum to “Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials”
Auteur:
Franzoi, M.A. Ameye, L. Eiger, D. Piccart, M. Brandão, M.D.R.A. Pondé, N. Desmedt, C. Di Cosimo, S. Paesmans, M. Caparica, R. Kotecki, N. Lambertini, M. De Angelis, C. Awada, A.H. de Azambuja, E.